In a recent issue, it was stated that adhesion molecules on the surface of myeloid leukaemic cells have played an important role in leukostasis in the lung [1]. VCAM-1 or ICAM-1 adhesion molecules are very important in the attachment of leukaemic cells to vascular endothelial cells in the lung; however, the responsible molecule has not yet been identified. Recently, we have seen a case of acute myelogenous leukaemia (AML) with formation of endobronchial tumour in the lung. Infiltration by leukaemic cells may occur in many organs. However, the formation of a tumour mass (granulocytic sarcoma) is uncommon [2]. In a large series of patients with leukaemia of all types [3], only 4 of 109 had involvement of the bronchial submucosa. We report here a very rare case of AML with endobronchial granulocytic sarcoma, presenting as a bronchial submucosal tumour. A 32-year-old male was admitted to our department suffering from anaemia in June 1991. He was diagnosed as having AML(M2)from a bone marrow specimen and treatedwith behenoyl-cytosine arabinoside, dauno-mycin, 6-mercaptopurine and prednisolone;he achieved complete remission. In June 1992, he suffered a relapse. The physical examination at that time revealed no lymphadenopathy and normal lung sounds. His laboratory data showed the following: haemoglobin 9.0 g/dl, platelet count 37 × 109/1, whiteblood cell count 2.5 × 109/1 with 7% neutro-phils, 60% lymphocytes and 33% blast cells.A bone marrow biopsy revealed hypocellularmarrow with 60% blast cells. Surface markeranalysis (using a fluorescence-activated cellsorter, FACScan, Beckton-Dickinson, Calif., USA) showed that the blast cells were CD2+, CD7+, HLA-DR+, CD33+, CD10-, CD34-, CD19-, CD41-, CD42-CDllb+, VLA4+, VLA5+, CD44++, VLA2-, CD54-, and CD62-. The patient received chemotherapy with mitoxanthorone, cytosine arabinoside, and etoposide, but did not respond. In October 1992 he started complaining of a productive cough and a chest radiograph and computed tomography scan revealed a right upper lobe atelectasis and lung infiltration. Bronchoscopy revealed a bronchial submucosal tumour between B2 and B3. He received 475 mg/day of carboplatin for 5
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